Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mattdoug
    Junior Member
    • Apr 2017
    • 1

    #1

    HISAT2 not reporting all splice sites?

    I'm using HISAT2 (version 2.0.5) to try and find novel splice sites. Going through the SAM file it produces suggests that there are a number of alignments supporting the existence of splice junctions that are not being reported (i.e. the aren't in the file you get from using the "--novel-splicesite-outfile" option).

    For example, the SAM record for one of the reads is:

    SRR360120.14138165 83 V 12814114 60 9M1297N91M = 12813953 -261 ATCCCATGTCTTAATTAAACTTGTGGTAACTTTTAATGAATTAAACTTCTGATTTTGCCGATAAGCATATCATATGAAAAATACTAAAAATGTCGAAATGCC?CCCCDECEEEEC?D@FFDEECHHGEEGDEFHAGGIGJIIIHHGIJIGHCGDIJJGIIGHHCG@E?A9EAGIEGF@HHBFAJIGJHFF<FADBFF@@@ AS:i:0 XN:i:0 XM:i:0 XO:i:0 XG:i:0 NM:i:0 MD:Z:100 YS:i:251 YT:Z:CP XS:A:- NH:i:1

    The way it's split suggests that there is a splice junction at V:12814123-12815419, but there's no such entry in the file of reported splice sites.

    For comparison, I ran TopHat (version 2.1.0) and it produced the same alignment for this read. The difference is that TopHat DOES report the expected splice junction at V:12,814,123-12,815,419.

    So, is there some criteria I'm missing that causes HISAT2 to not report certain splice junctions, even if there are alignments supporting them?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...